Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Gnai3em1flox/Cya
Common Name:
Gnai3-flox
Product ID:
S-CKO-02675
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gnai3-flox
Strain ID
CKOCMP-14679-Gnai3-B6J-VA
Gene Name
Gnai3
Product ID
S-CKO-02675
Gene Alias
Galphai3; Gnai-3; Hg1a
Background
C57BL/6JCya
NCBI ID
14679
Modification
Conditional knockout
Chromosome
3
Phenotype
MGI:95773
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gnai3em1flox/Cya mice (Catalog S-CKO-02675) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000000001
NCBI RefSeq
NM_010306
Target Region
Exon 2~3
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Gnai3, also known as Guanine nucleotide binding protein, alpha inhibiting activity polypeptide 3, is involved in multiple biological processes. It plays roles in signal transduction pathways, such as those related to G-protein coupled receptors. Inhibitory G proteins like Gnai3 are crucial in regulating various cellular functions, including cell growth, differentiation, and inflammation [5,6,7,8,9]. Genetic models, like the Gnai3-iresGFP reporter mouse line, are valuable tools for studying Gnai3 expression patterns [3].

In a mouse model, GNAI1 and GNAI3 double-knockout (DKO) mice showed more severe colitis and significantly more colonic tumors compared to control mice. This indicates that GNAI3 suppresses DSS-plus-AOM-induced colon tumor development, possibly by blocking IL6 signaling and down-regulating GNAI2 expression [2]. In hepatocellular carcinoma (HCC), down-regulation of GNAI3 by miR-222 promoted cell migration and invasion, and low GNAI3 expression predicted poor prognosis in HCC patients [4,8]. In non-alcoholic fatty liver disease (NAFLD) mouse and cell models, GNAI3 knockout enhanced dysregulated hepatic lipid metabolism and liver damage, suggesting GNAI3 is a potential target for NAFLD treatment [6]. In periodontal stem cells, GNAI3, mediated by Lin28A, regulated lipopolysaccharide-induced inflammation and osteogenic differentiation via the NF-κB/NLRP3 inflammasome pathway [1]. Also, in osteoblast precursor cells, Gnai3 regulated cell proliferation, migration, osteogenic differentiation, and mineralization through the MAPK signaling pathway, and its mutation was related to congenital small jaw deformity [9].

In conclusion, Gnai3 is essential in regulating multiple biological processes. Model-based research, especially gene knockout mouse models, has revealed its significant roles in various disease areas, including colon cancer, HCC, NAFLD, periodontitis, and congenital mandibular defects. These findings provide potential therapeutic targets and a better understanding of the underlying disease mechanisms related to Gnai3.

References:
1. Guo, Ling, Sun, Hua, Pu, Jiao. 2024. GNAI3 mediated by Lin28A regulates lipopolysaccharide-induced inflammation and osteogenic differentiation in periodontal stem cells by mediating the NF-κB/NLRP3 inflammasome pathway. In Archives of oral biology, 163, 105974. doi:10.1016/j.archoralbio.2024.105974. https://pubmed.ncbi.nlm.nih.gov/38636252/
2. Li, Zhi-Wei, Sun, Beicheng, Gong, Ting, Zhou, Xiqiao, Chu, Wen-Ming. 2019. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2. In Gastroenterology, 156, 2297-2312. doi:10.1053/j.gastro.2019.02.040. https://pubmed.ncbi.nlm.nih.gov/30836096/
3. Leiss, Veronika, Reisinger, Ellen, Speidel, Annika, Beer-Hammer, Sandra, Nürnberg, Bernd. 2021. Analyses of Gnai3-iresGFP reporter mice reveal unknown Gαi3 expression sites. In Scientific reports, 11, 14271. doi:10.1038/s41598-021-93591-0. https://pubmed.ncbi.nlm.nih.gov/34253772/
4. Zhang, Yu, Yao, Jian, Huan, Lin, Liang, Linhui, He, Xianghuo. 2014. GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. In Cancer letters, 356, 978-84. doi:10.1016/j.canlet.2014.11.013. https://pubmed.ncbi.nlm.nih.gov/25444921/
5. Mishra, Chinmoy, Mohapatra, Swagat. . An integrative bioinformatics analysis of caprine GNAI3 gene. In Journal of genetics, 99, . doi:. https://pubmed.ncbi.nlm.nih.gov/32366735/
6. Zhu, Hanzhang, Ge, Ke, Lu, Jun, Jia, Changku. . Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease. In Gut and liver, 14, 492-499. doi:10.5009/gnl19115. https://pubmed.ncbi.nlm.nih.gov/31694365/
7. Young, Alejandra, Dandekar, Uma, Pan, Calvin, Lewis, Richard A, Farber, Debora B. 2016. GNAI3: Another Candidate Gene to Screen in Persons with Ocular Albinism. In PloS one, 11, e0162273. doi:10.1371/journal.pone.0162273. https://pubmed.ncbi.nlm.nih.gov/27607449/
8. Chen, Guodong, Li, Xiaoyan, He, Gengsheng, He, Jun, Huang, Zonghai. 2015. Low expression of GNAI3 predicts poor prognosis in patients with HCC. In International journal of clinical and experimental medicine, 8, 21482-6. doi:. https://pubmed.ncbi.nlm.nih.gov/26885096/
9. Meng, Li, Yuan, Lichan, Ni, Jieli, Ma, Junqing, Zhang, Yang. 2021. Mir24-2-5p suppresses the osteogenic differentiation with Gnai3 inhibition presenting a direct target via inactivating JNK-p38 MAPK signaling axis. In International journal of biological sciences, 17, 4238-4253. doi:10.7150/ijbs.60536. https://pubmed.ncbi.nlm.nih.gov/34803495/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest